miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.

Fang Y, Liang X, Xu J, Cai X

Open source

DOI
10.2147/cmar.s185789
Published
2018
Container
Cancer management and research
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/cmar.s185789,
  title = {miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.},
  author = {Fang Y and Liang X and Xu J and Cai X},
  year = {2018},
  journal = {Cancer management and research},
  doi = {10.2147/cmar.s185789},
  url = {https://doi.org/10.2147/cmar.s185789}
}

RIS

TY  - JOUR
TI  - miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.
AU  - Fang Y
AU  - Liang X
AU  - Xu J
AU  - Cai X
PY  - 2018
JO  - Cancer management and research
DO  - 10.2147/cmar.s185789
UR  - https://doi.org/10.2147/cmar.s185789
ER  - 

APA

Y, F., X, L., J, X., & X, C. (2018). miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer.. Cancer management and research. https://doi.org/10.2147/cmar.s185789

Source records